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ABSTRACT 
The effect of phosphorylated glucose on major pathogens of bovine mastitis 
 
Kendall Schaefer 
Department of Animal Science  
Texas A&M University 
 
Research Advisor: Dr. Jeffrey Musser  
Department of Veterinary Pathobiology  
 
Mastitis is the number one infectious disease on dairies. Treatment and prevention is mainly 
through good milking hygiene, proper environmental conditions, and antibiotic usage. For 
organic dairies, mastitis prevention and control can be problematic as there are major restrictions 
on the use of antibiotics. Phosphorylated glucose, produced by heating (121ºC) a phosphate-
buffered solution with added glucose, is bactericidal to Escherichia coli. We tested the 
bactericidal properties of phosphorylated glucose on three major pathogens of mastitis: E. coli, 
Staphylococcus aureus, and Streptococcus agalactiae. Phosphorylated glucose was bactericidal 
on the pathogens tested in phosphate-buffered saline. When in the presence of milk, 
phosphorylated glucose was not bactericidal on E. coli, but Staph. aureus and Strep. agalactiae 
are still affected. Further studies of phosphorylated glucose on Mycoplasma, a pathogen of 
mastitis that is inherently resistant to β-lactam antibiotics, and on mammary cells are in process. 
This work will provide organic dairy producers with additional information for the prevention 
and treatment of mastitis. 
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NOMENCLATURE 
 
CFU   Colony Forming Units 
E. coli   Escherichia coli 
M. bovis  Mycoplasma bovis 
MRSA   Methicillin-Resistant Staphylococcus aureus 
PBS   Phosphate Buffered Saline 
Phos 1% Gluc  Heat- and phosphate-catalyzed 1% glucose  
Staph. aureus  Staphylococcus aureus 
Strep. agalactiae Streptococcus agalactiae  
TSA   Tryptic soy agar 
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SECTION I 
INTRODUCTION 
 
Bovine mastitis in the dairy industry 
Bovine mastitis is primarily caused by a bacterial infection. These pathogens can be 
differentiated into two categories of pathogens, contagious and environmental pathogens. 
Contagious pathogens, such as Staphylococcus aureus, Streptococcus agalactiae and 
Mycoplasma bovis, are transmitted from cow to cow during the milking procedure and routinely 
cause chronic subclinical infections (NMC, 2011). Coliform bacteria, Escherichia coli being the 
prototypical bacteria, are environmental pathogens that are acquired from the cow’s environment 
with transmission usually occurring during the period between milkings (NMC, 2010).  
 
Annually in the U.S., the cost of mastitis to the dairy industry is about $1.7-2 billion, 
representing an 11% loss of total milk production (Jones 2009). This loss is due to reduced milk 
production, discarded milk, and replacement animals; indirect losses in consumer consumption 
due to reduced quality, taste, and shelf-life also occur. Proper milking hygiene, good facilities, 
cow management, and dry-cow antibiotic treatment are essential for the prevention of mastitis, 
while antibiotic treatments are the main tool in the treatment of mastitis. However, the use of 
antibiotics is restricted on organic dairies.  
   
Antibiotic use in mastitis treatment and prevention 
While antibiotics are heavily restricted on organic dairies, commercial dairies routinely use 
antibiotics for treatment and prevention of mastitis. In the United States, approximately 90% of 
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all dairy cows are treated with antibiotics (Sjostrom, 2015). Excluding antibiotics used in 
medicated feed and water, most antibiotic use is for dry-cow treatment, which is the time period 
between the cessation of milking and the next lactation. Dry-cow treatment is a common practice 
for subclinical mastitis control (Østerås, 1999).  
 
Antimicrobial resistant bacteria have been found on dairies and potentially have a public health 
significance. Staph. aureus isolates were found to be penicillin and multidrug resistant, 9 and 
15% respectively, and E. coli isolates were found to be tetracycline and multidrug resistant, 15 
and 63% respectively (Saini et al., 2012). 
 
As to the issue of MRSA, it is theorized that the use of cloxacillin, which is used extensively as a 
dry-cow treatment, may increase the prevalence of MRSA (Saini et al., 2012).  Presently, few to 
no MRSA isolates have been reported from mastitic milk (Saini et al., 2012; Vanderhaeghen et 
al., 2010) and bulk tank milk is not a common source for MRSA isolates (Virgin et al., 2009). 
Although MRSA has the potential to complicate treatment of mastitis (Vanderhaeghen et al., 
2010), in commercially pasteurized milk, it should not be a major health issue. 
 
Heat- and phosphate-catalyzed glucose 
Heat- and phosphate-catalyzed glucose is bactericidal against E. coli O157:H7 on starvation 
media and in nutrient broths (Byrd, 1999). A phosphorylated 1% glucose solution reduces colony 
forming units (CFUs) of E. coli O157:H7 by 99.9% and has the potential to be used as an 
antimicrobial in processed food.  
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Due to the restrictions on antibiotic use on organic dairies and the increase in antibiotic resistant 
bacteria on dairy farms, alternative preventative measures and treatments for mastitis are desired. 
Phosphorylated glucose has shown bactericidal activity in other situations, thus it may be useful 
in mastitis prevention and treatment. We hypothesize that phosphorylated glucose will have 
antimicrobial properties against E. coli, Staph. aureus, and Strep. agalactiae.  
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SECTION II 
MATERIALS AND METHODS 
 
Bacteria and reagents 
All three pathogens, E. coli, Staph. aureus, and Strep. agalactiae, were obtained from stored 
archival samples at -80º C. Bacteria were thawed, Strep. agalactiae was cultured on blood agar 
media, and E. coli and Staph. aureus were cultured on TSA media. The cultures were incubated 
at 37º C for 24 hours. The bacteria were removed from incubation to be utilized for the project. 
This process was repeated for each experiment. 
 
Phosphorylated glucose was made by adding glucosea to PBSb to achieve a final concentration of 
1% glucose. The solution was then autoclaved at 121ºC for 15 minutes. This solution, Phos 1% 
Gluc, was used for all experiments. A fresh solution was made for each experiment.   
 
Pasteurized skim milkc was used in all experiments involving the efficacy of Phos 1% Gluc 
against these bacteria in the presence of milk.  
 
Experimental protocol 
Using the 24 hour bacterial cultures, a bacterial suspension in PBS, at a concentration equal to a 
0.5 McFarland standard, was made from each bacteria. Two concentrations of bacteria were 
tested: a 0.5 McFarland and a 1:10 dilution of the 0.5 McFarland. Three milliliters of each 
bacterial suspension were added to 3 mL of Phos 1% Gluc. These suspensions were incubated at 
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37ºC and used throughout the experiment, with a fresh bacterial suspension being made in each 
section. 
  
Bactericidal properties of phosphorylated 1% glucose in PBS 
To test the bactericidal properties of Phos 1% Gluc in PBS, a 0.5 McFarland and a 0.05 
McFarland standard were made from the 24 hour bacterial cultures. Streptococcus agalactiae 
was cultured on blood agar media and E. coli and Staph. aureus were cultured on TSA at times 
t=0, 24, and 48 hours for each concentration of each bacteria. The plates were incubated for 24 
hours, the CFU were counted, and the bacteria solutions were incubated throughout.  
 
Time to bactericidal effect in PBS 
The experimental protocol was used. The bacteria were streaked at times t = 0, 1, 2, 4, 6, 8, and 
24 hours. The plates were incubated for 24 hours. 
 
Bactericidal properties of phosphorylated 1% glucose in skim milk 
The experimental protocol was used for the preparation of a 0.5 McFarland standard. For each 
bacteria, a 1:5 dilution was performed on the 0.5 McFarland standard. One and a half milliliters 
of the 1:5 dilution were added to 1.5 mL of skim milk, giving a 1:10 dilution in the presence of 
skim milk. Three different concentrations were made: 1:1, 5:1, and 10:1, Phos 1% Gluc to skim 
milk solution.  
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Blood agar media (Strep. agalactiae) and TSA media (E. coli, Staph. aureus) were streaked at 
times t=0 hours, t=24 hours, and t=48 hours for each concentration of each bacteria. The plates 
were incubated for 24 hours and the bacteria solutions were incubated throughout.  
 
Statistical analysis 
Descriptive statistics, mean, minimum, and maximum were reported. 
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SECTION III 
RESULTS 
 
Bactericidal properties of phosphorylated 1% glucose in PBS 
For all three bacteria, the addition of Phos 1% Gluc to the bacteria reduced the number of CFU, 
and there was a greater reduction with increased contact time with the Phos 1% Gluc (Table 1). 
Incubation of the bacterial suspension with Phos 1% Gluc for 24 and 48 hours reduced the CFU 
greatly; 100% reduction of CFU was seen at 24 hours for all three bacteria, with the exception of 
E. coli at the 0.5 McFarland concentration. 
 
Following the seven days of further incubation of the culture plates with no CFU, no bacteria 
were observed.  
 
Table 1. Phosphorylated 1% Glucose in PBS 
Time 
exposed 
[hrs] 
 E. coli 
[CFU* (range)] 
 Staph. aureus 
[CFU (range)] 
 Strep. agalactiae 
[CFU (range)] 
 0.5 0.05  0.5 0.05  0.5 0.05 
          
0 
 
 TNTC** >350  TNTC TNTC  TNTC TNTC 
24 
 
 83 (0, 250) 0  155 (23, 400) 44 (10, 100)  27 (0, 52) 8 (0, 24) 
48  58 (0, 175) 0  0 0  0  0 
 
* CFU = colony forming units 
** TNTC = too numerous to count 
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Time to bactericidal effect in PBS 
After 8 hours of contact between Phos 1% Gluc and the bacteria, a reduction in CFU was noted, 
with no CFU observed at 24 hours (Table 2).   
 
Table 2. Time to Bactericidal Effect in PBS 
 
 
* CFU = colony forming units 
** TNTC = too numerous to count 
 
Bactericidal properties of phosphorylated 1% glucose in skim milk 
The addition of skim milk to the suspension reduced the efficacy of the Phos 1% Gluc for all 
three bacteria (Table 3). The bactericidal effect of Phos 1% Gluc on E. coli was negated by the 
addition of skim milk. However, Strep. agalactiae was still sensitive to Phos 1% Gluc in the 
presence of skim milk. At the 5:1 concentration of Phos 1% Gluc to bacteria, the presence of 
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CFU was reduced by 85% by 24 hours. The 10:1 concentration was more effective, with 100% 
reduction of CFU at 48 hours.  
 
Table 3.  Phosphorylated 1% Glucose in Skim Milk 
Time 
exposed 
[hrs] 
 E. coli 
[CFU* (range)] 
 Staph. aureus 
[CFU (range)] 
 Strep. agalactiae 
[CFU (range)] 
 5:1¶ 10:1  5:1 10:1  5:1 10:1 
          
0 
 
 300 (200, 400) 275 (250, 300)  230 (190, 300) 177 (31, 250)  250 (200, 300) 170 (150, 200) 
24 
 
 TNTC** TNTC  230 (120, 300) 129 (67, 200)  33 (11, 70) 5 (1, 12) 
48  TNTC TNTC  317 (250, 400) 27 (18, 39)  10 (0, 19) 0 
 
* CFU = colony forming units 
¶ ratio Phos 1% Gluc to milk 
** TNTC = too numerous to count 
 
13 
 
SECTION IV 
DISCUSSION 
 
Heat- and phosphate-catalyzed 1% glucose has a bactericidal effect on E. coli, Staph. aureus, and 
Strep. agalactiae. Following seven days of further incubation of cultures, no bacterial growth 
was noted, suggesting that the effect is bactericidal and not bacteriostatic. However, the 
bactericidal effect is time, bacterial concentration, and suspension medium dependent. Bacteria 
need to be in contact with the Phos 1% Gluc for a minimum of eight hours before the bactericidal 
effect is noted, but a 100% reduction in CFU was seen following 24 hours of contact time. This 
factor may play a role in the usefulness of Phos 1% Gluc in mastitis treatment and prevention, as 
multiple intramammary infusions over a 24 hour period may be required for efficacy.  
 
Additionally, the presence of skim milk affected the ability of Phos 1% Gluc to reduce bacterial 
numbers. Heat- and phosphate-catalyzed 1% glucose had no effect on E. coli when milk was 
added; in fact, CFU tended to increase. The mechanism for this is unknown, but it is possible 
that E. coli is able to use a different substrate present in the milk in the place of the Phos 1% 
Gluc. The presence of milk inhibited the effect of Phos 1% Gluc on Staph, aureus and Strep. 
agalactiae (Table 3). When the ratio of Phos 1% Gluc to milk was increased, the bactericidal 
effect was also increased. At a 10:1 (Phos 1% Gluc: milk) ratio, Strep. agalactiae was least 
affected by the presence of milk, as CFU were greatly reduced to 95 and 100% of original 
numbers at 24 and 48 hours, respectively. This reduction was comparable to the reduction 
observed when milk was not present (Table 1). This finding is noteworthy as Strep. agalactiae is 
a contagious, obligate bacteria of the mammary gland, thus eradication from a herd is achievable 
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with proper antibiotic and dry-cow treatment. Due to antibiotic usage restrictions on organic 
dairies, Phos 1% Gluc may be a useful treatment in the management and eradication of Strep. 
agalactiae on these dairies.  
 
Further research is needed before clinical trials on the effect of Phos 1% Gluc in mastitis 
prevention and treatment can be done. These studies should include: repeated time trials on 
bactericidal effect, cytotoxicity of Phos 1% Gluc on mammalian cells, and the bactericidal effect 
of Phos 1% Gluc on M. bovis.  
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APPENDIX A 
 
 
 
a Sigma-Aldrich, St. Louis, MO 
b Sigma-Aldrich, St. Louis, MO 
c purchased from HEB, College Station, TX 
 
